Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

IKTIKT
13 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in INHIBIKASE THERAPEUTICS INC

GEODE CAPITAL MANAGEMENT, LLC holds 2.6M shares of IKT (INHIBIKASE THERAPEUTICS INC), worth $5.3M as of 2026-Q2. The position was increased (+20.1% shares). IKT represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$5.3M

Current Shares

2.6M

Total Value Change

+$5.2M

Total Shares Change

+2.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.6M
+20.1%
$5.3M0.0%$2.03
32
2026-Q1
Increased
2.2M
+92.3%
$3.6M0.0%$1.91
42
2025-Q4
Increased
1.1M
+1.4%
$2.3M0.0%$1.97
26
2025-Q3
Increased
1.1M
+4.3%
$1.8M0.0%$1.53
27
2025-Q2
Increased
1.1M
+228.5%
$2.1M0.0%$1.62
42
2025-Q1
Increased
324,760
+0.6%
$711,2850.0%$2.29
25
2024-Q4
Increased
322,878
+544.9%
$1M0.0%$3.24
40
2024-Q3
Increased
50,065
+34.1%
$65,1130.0%$1.17
18
2024-Q2
Increased
37,330
+30.1%
$48,9320.0%$1.21
18
2024-Q1
Unchanged
28,692
0.0%
$62,0230.0%$2.16
0
2023-Q4
Unchanged
28,692
0.0%
$36,4650.0%$1.27
0
2023-Q3
Increased
28,692
+93.3%
$40,4880.0%$1.39
22
2023-Q2
New
14,840
-
$51,6430.0%$3.66
31

Other major holders of IKT: BlackRock, Inc., Blackstone Inc., VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used